Profile data is unavailable for this security.
About the company
EZZ Life Science Holdings Limited is an Australia-based genomic life science company. The Company is engaged in research and development in genomics and precision nutrition with a focus on four human health challenges, including genetic longevity, human papillomavirus (HPV), helicobacter pylori, and weight management. It formulates, produces, markets and distributes health supplements under the brand of EZZ to retailers and consumers domestically and internationally. The Company is also a wholesale distributor of skin care products under the EAORON brand in Australia and New Zealand to pharmacies, supermarkets and specialist retailers. Its products under the EZZ brand include EZZ Hair Growth Spray, EZZ Hair Scrub, EZZ Hair Mask, EZZ Anti-frizz Hair Spray, EZZ Biotic Engastro Capsule, EZZ Coffee Jelly and EZZ Iron Jelly. The EZZ products cover market segments, including vitamin and dietary supplements, sports nutrition, herbal/ traditional and pediatric consumer health products.
- Revenue in AUD (TTM)66.44m
- Net income in AUD6.96m
- Incorporated2015
- Employees--
- LocationEZZ Life Science Holdings Ltd104 Derby StreetSYDNEY 2128AustraliaAUS
- Phone+61 28002-1376
- Websitehttps://ezzlife.com.au/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Syntara Ltd | 5.43m | -13.67m | 41.29m | 107.00 | -- | 8.16 | -- | 7.61 | -0.0157 | -0.016 | 0.0057 | 0.0039 | 0.3155 | -- | 0.7918 | -- | -79.44 | -30.68 | -130.63 | -40.26 | -- | -- | -251.77 | -74.66 | -- | -484.90 | 0.0474 | -- | -7.92 | -15.43 | -1.77 | -- | -62.79 | -- |
Vitura Health Ltd | 123.87m | 3.51m | 43.77m | 121.00 | 12.32 | 1.13 | 8.96 | 0.3533 | 0.0062 | 0.0062 | 0.2165 | 0.0674 | 2.10 | 15.04 | 10.74 | -- | 5.50 | 13.50 | 7.70 | 18.51 | 27.63 | 32.41 | 2.62 | 6.19 | 1.11 | 30.48 | 0.2228 | -- | 5.56 | -- | -74.57 | -- | 155.80 | -- |
Starpharma Holdings Ltd | 9.76m | -8.17m | 43.82m | 50.00 | -- | 1.54 | -- | 4.49 | -0.0198 | -0.0198 | 0.0237 | 0.0682 | 0.2195 | 0.244 | 1.20 | -- | -18.37 | -27.20 | -24.10 | -33.05 | 93.52 | 77.48 | -83.69 | -269.74 | 4.58 | -- | 0.1115 | -- | 131.84 | 29.10 | 47.79 | -- | -22.29 | -- |
Oncosil Medical Ltd | 387.46k | -12.38m | 49.19m | 2.00 | -- | 9.43 | -- | 126.96 | -0.0056 | -0.0056 | 0.0002 | 0.0014 | 0.0435 | -- | 0.2937 | -- | -138.79 | -68.47 | -170.28 | -78.28 | -256.87 | -- | -3,193.94 | -800.23 | -- | -38.98 | 0.0152 | -- | -9.95 | -36.76 | -9.10 | -- | -- | -- |
Medical Developments International Ltd | 33.15m | -40.99m | 51.26m | 68.00 | -- | 0.8815 | -- | 1.55 | -0.4627 | -0.4627 | 0.3741 | 0.5162 | 0.4131 | 1.02 | 4.14 | -- | -51.09 | -15.81 | -60.56 | -17.79 | 73.50 | 70.98 | -123.66 | -52.49 | 1.82 | -- | 0.0476 | -- | 2.51 | 9.22 | -630.83 | -- | -20.32 | -- |
Next Science Ltd | 34.46m | -19.96m | 54.05m | -- | -- | 5.16 | -- | 1.57 | -0.0743 | -0.0743 | 0.1264 | 0.0358 | 1.97 | 5.34 | 8.04 | -- | -113.88 | -74.40 | -168.92 | -90.31 | 78.83 | 76.98 | -57.93 | -128.26 | 1.96 | -- | 0.1045 | -- | 89.36 | 50.80 | -28.29 | -- | -2.28 | -- |
Radiopharm Theranostics Ltd | 299.23k | -47.95m | 73.88m | -- | -- | 0.5566 | -- | 246.90 | -0.1261 | -0.1261 | 0.0008 | 0.0611 | 0.0041 | -- | 0.1097 | -- | -65.24 | -- | -82.85 | -- | -- | -- | -16,024.17 | -- | -- | -3.46 | -- | -- | 2.35 | -- | -38.54 | -- | -- | -- |
PharmAust Limited | 866.18k | -8.90m | 82.69m | 52.00 | -- | 7.40 | -- | 95.47 | -0.0234 | -0.0199 | 0.0023 | 0.023 | 0.1004 | -- | 10.39 | -- | -103.16 | -31.15 | -118.57 | -35.11 | -- | -- | -1,027.49 | -105.37 | -- | -- | 0.00 | -- | -8.78 | -27.63 | -466.09 | -- | -- | -- |
Recce Pharmaceuticals Ltd | 5.24m | -17.66m | 118.12m | -- | -- | -- | -- | 22.56 | -0.0999 | -0.0999 | 0.0296 | -0.0467 | 1.17 | -- | 41.87 | -- | -395.76 | -136.12 | -- | -226.28 | -- | -- | -337.29 | -373.28 | -- | -19.86 | -- | -- | 18.17 | 50.13 | -35.06 | -- | 9.55 | -- |
Vita Life Sciences Limited | 78.92m | 9.41m | 131.41m | 124.00 | 13.57 | 2.69 | 13.29 | 1.67 | 0.1717 | 0.1717 | 1.44 | 0.865 | 1.29 | 2.33 | 6.94 | -- | 15.37 | 15.25 | 21.18 | 21.99 | 58.48 | 60.90 | 11.90 | 11.71 | 2.18 | -- | 0.0088 | 39.05 | 10.88 | 12.50 | 28.18 | 30.07 | 12.15 | 19.14 |
EZZ Life Science Holdings Ltd | 66.44m | 6.96m | 138.57m | -- | 19.41 | 6.50 | 18.84 | 2.09 | 0.1607 | 0.1607 | 1.54 | 0.4801 | 3.08 | 13.79 | 33.30 | -- | 32.25 | 24.12 | 38.61 | 31.19 | 76.67 | 65.40 | 10.48 | 9.81 | 5.63 | 482.42 | 0.0058 | -- | 78.88 | 42.81 | 91.87 | 53.25 | 176.34 | -- |
Biome Australia Ltd | 13.07m | -1.67m | 177.49m | 30.00 | -- | 60.00 | -- | 13.58 | -0.0082 | -0.0082 | 0.0628 | 0.0135 | 1.65 | 2.08 | 6.06 | -- | -21.09 | -70.48 | -43.35 | -106.49 | 61.01 | 60.22 | -12.78 | -61.42 | 1.13 | -10.02 | 0.4829 | -- | 76.05 | 103.19 | 45.75 | -- | -47.07 | -- |